Brentuximab vedotin is now listed in the interaction checker as a cancer drug and interactions can be found with all the comedications.
Brentuximab vedotin (Adcetris®) is an antibody-drug conjugate and is indicated for the treatment of Hodgkin disease and Non-Hodgkin lymphoma.
